Document Details

MGEN $9.02   $ (0.03) (0.33)%
Document Details

Filing Type

8-K/A (SEC's EDGAR System)

Company Miragen Therapeutics (Boulder, CO)
Event Date 2/13/2017
Filing Date 3/31/2017

Abstract: 8-K filed by Miragen Therapeutics covering Financial Statements and Exhibits.

File Section(s)

  1. 8-K/A
  2. EX-99.1
  3. EX-99.2

Note: This document was filed with the SEC in HTML format, as allowed by the recent EDGAR system modernization. S&P cannot take responsibility for its appearance, layout, or legibility.